Title of Activity: Radiation Oncology Webinar Series, "Intracranial Stereotactic Radiosurgery: Radiographic Changes after SRS and Management of Post-Treatment Toxicity"
Date of Activity: May 29, 2024
Educational/Learning Objectives
After completing this activity, the participant should be better able to:
- Explain the history and current state of emerging radiation oncology treatment technologies.
- Identify research opportunities and clinical trials currently available related to emerging radiation oncology treatment technologies.
- Review active utilization of emerging radiation oncology treatment technologies domestically and abroad.
- Discuss future directions of emerging radiation oncology treatment technologies and the potential implications.
This webinar will cover radiographic changes seen on post-treatment imaging in patients with intracranial malignancies who have received stereotactic radiosurgery. National experts in radiology will review findings seen on post-treatment imaging, providing attendees the knowledge to understand how to differentiate between progression, pseudoprogression, necrosis, and benign radiographic changes. National experts in radiation oncology will then discuss options for management in patients who experience post-treatment toxicity after stereotactic radiosurgery.
Physician Accreditation Statement
The American College of Radiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation
The American College of Radiology designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Each session in this Webinar Series is designated for 1.0 AMA PRA Category 1 Credit™ for a total of 4.0 AMA PRA Category 1 Credits™ for the series.
Instructions to Receive Credit
In order to successfully complete the activity, participants must complete an activity evaluation and claim credit commensurate with their participation in the activity.
Contact Information
For information about the accreditation of this program, please contact the ACR at info@acr.org.
Disclosure of Relevant Financial Relationships
The ACR Disclosure Policy: The American College of Radiology (ACR) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ACR are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ACR in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ACR to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ACR.
The following planners and managers have no relevant financial relationships to disclose: Arya Amini, MD; Emile Gogineni DO; Theresa Rudolph; Alexis LaCount
The following faculty members have no relevant financial relationships: Arya Amini, MD and Emile Gogineni, DO